Rhode Island Medical Imaging (RIMI) has been named a Lung Cancer Screening Center of Excellence by the GO2 Foundation for Lung Cancer. RIMI is the first and only GO2-designated imaging provider in Rhode Island. This designation makes RIMI a part of more than 680 facilities nationwide that have an ongoing commitment to responsible lung cancer screening.

“RIMI’s top priority is caring for our patients with the most advanced practices within our field,” said Siobhain Sullivan, RIMI’s chief operating officer, clinical operations. “This includes our specially-trained radiologists and our use of the latest equipment and processes. We are honored to be recognized by the GO2 Foundation for our efforts and to be the first to represent our state in this designation nationally.”

GO2 Screening Centers of Excellence comply with comprehensive standards reflecting best practices developed by professional bodies such as the American College of Radiology (ACR), the National Comprehensive Cancer Network (NCCN) and the International Early Lung Cancer Action Program (I-ELCAP). RIMI also holds several ACR designations, including as an ACR Diagnostic Imaging Screening Center of Excellence and an ACR Lung Cancer Screening Center.

“We are proud and honored to be working with Rhode Island Medical Imaging as a GO2 Foundation for Lung Cancer Screening Center of Excellence,” said GO2 Foundation Co-Founder, President and CEO, Laurie Fenton Ambrose. “RIMI’s commitment to practice responsible lung cancer screening will lead to advancements in research and many lives saved. They are an example to follow.”

According to the American Lung Association (ALA), lung cancer is the leading cause of cancer deaths in both men and women in the U.S., surpassing breast cancer deaths for women. ALA’s most recent 2020 ‘State of Lung Cancer’ Report shares that an estimated 920 Rhode Islanders will be diagnosed with lung cancer in 2020. And while Rhode Island ranks as a top 10 state in lung cancer screening, diagnosis and treatment, there is an increasing rate of lung cancer in the state and still many disparities to address.